MedCity News

From Fee-for-Service to Value-Based Care: Enhancing Outcomes in Nephrology

With FDA Nod in Lung Cancer, Dizal Now Aims to Best a J&J Drug and Succeed Where Takeda Fell Short

Dizal Pharmaceutical’s Zegfrovy is now FDA approved for treating non-small cell lung cancer driven by a particular rare genetic signature. Johnson & Johnson drug Rybrevant already addresses this genetic signature as an earlier line of therapy, but Dizal executives contend their drug offers the potential for better safety and efficacy.

By Frank Vinluan

Startups, Devices & Diagnostics, Artificial Intelligence

Eko Health’s AI for Cardiac Diagnoses Earns CMS Reimbursement Rate

This week, CMS established a reimbursement code for Eko Health’s AI platform, which seeks to aid clinicians in the diagnosis of heart conditions. The goal behind the technology is to help catch heart disease earlier, when it’s easier to treat, and to make high quality diagnostic care more accessible.

By Katie Adams

Opinion

What Administering My Father’s Home Infusions for 10 Years Taught Me About Improving Chronic Illness Care

It became clear to me that if my father’s life could be drastically improved with routine at-home care, so could many others. The next frontier in healthcare isn't just about new medications or diagnostic tools; it's about reimagining how and where we deploy our existing clinical expertise.

By Ryan Johnson

Latest News

MedCity Influencers

From Magic Bullets to Medical Insights: How RFK Jr.’s Critique Shapes the Future of Pharma Advertising

But where do truth and trust originate in healthcare marketing? They emerge from various sources such as digital advertising, educational campaigns, patient journeys, and partnerships with healthcare providers who uphold truth in advertising standards.

By Leslie Wheeler

MedCity Influencers

AI Is No Longer Optional in Senior Living – Here’s Why

Now is the time for senior living leaders to act and re-imagine what resident-centered, modern care can look like, today and in the future.

By Michael Wang

MedCity Influencers

From Hype to Impact: How Pharma Can Use Agentic AI to Drive Efficiency and Trust

Success with agentic AI won’t come from racing to adopt the flashiest tools. It will come from strategic alignment, understanding where AI can create real value, mitigating risk through thoughtful implementation, and ensuring transparency and oversight at every step.

By Basia Coulter

AI-Driven Email Attacks Are Exploding. Is Your Healthcare Organization at Risk?

AI-powered threats are overwhelming outdated IT defenses. Discover why email remains healthcare’s biggest cybersecurity vulnerability and what can be done to address it.

By Stephanie Baum

BioPharma, Pharma

FDA Approves Regeneron Multiple Myeloma Drug With Dosing Edge Over J&J and Pfizer Meds

Bispecific antibodies are already available for treating multiple myeloma. FDA approval of Regeneron Pharmaceuticals’ new drug, Lynozyfic, comes with dosing flexibility that sets it apart from others in its class.

By Frank Vinluan

Artificial Intelligence, Health Tech

Nordic Capital Acquires Arcadia, Entering the VBC Space

Nordic Capital acquired a majority stake in health data platform Arcadia. Together, the two aim to accelerate the company’s mission of advancing value-based care through AI and data analytics. Arcadia CEO Michael Meucci views the deal as both a validation of the company’s strategy and part of a broader wave of healthcare investments focused on interoperability, AI and payment reform.

By Katie Adams

BioPharma, Pharma

Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test

Organon said OG-6219 did not beat a placebo in a mid-stage clinical trial whose main goal was to measure the change in pelvic pain caused by endometriosis. The twice-daily pill came from Organon’s 2021 acquisition of Forendo Pharma.

By Frank Vinluan

What Are Healthcare Organizations Getting Wrong about Email Security?

A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.

By Paubox and MedCity News

MedCity Influencers

Industry Pressures and Possibilities: What’s Ahead for Skilled Nursing Facilities

To remain resilient amid the volatility, skilled nursing facilities s need to stay on top of what’s impacting operations and consider strategic opportunities. Here are important trends to watch.

By Denise Leonard

MedCity Influencers

Physician-led AI: Unlocking Clinical Productivity In Prior Authorization

By keeping our AI and ML grounded in real-world medicine, we can shape a future where prior authorization works smarter, faster, and better for everyone involved.

By Dr. Paul Johnson

MedCity Influencers

Navigating Co-Occurring ADHD and Eating Disorders

Co-occurring ADHD and eating disorders can intensify the symptoms of each other. Impulsivity can lead to binge eating or purging and emotional dysregulation can make it challenging to cope with life’s difficulties. Addressing both ADHD and an eating disorder at the same time can best forge the path to recovery and healthy coping.

By Brad Smith

Ochsner Health Scales AI Tool After Its Cuts Prior Authorization Time to Just 4-5 Minutes

Ochsner Health is expanding its use of Latent Health’s AI platform after its reduced medication prior authorization times to just 4-5 minutes. The technology is designed to both streamline pharmacists’ workflows as well as improve patients’ access to medications.

By Katie Adams

BioPharma, Startups

MIT Spinout Syntis Bio Secures $33M for a Novel Approach to Treating Obesity and More

Instead of an engineered peptide to activate gut receptors to trigger metabolic effects, Syntis’s technology forms a coating in intestines that has the effect of redirecting nutrients, mimicking an effect of gastric bypass surgery. In other obesity medicine news, Protagonist Therapeutics revealed a drug candidate that puts it in competition with Novo Nordisk and Eli Lilly, among others.

By Frank Vinluan

Health Tech

Lilli Health Introduces App for Managing PCOS

The new Lilli App helps consumers manage polycystic ovary syndrome with meal plans, a symptom tracking tool and educational resources.

By Marissa Plescia

MedCity Influencers

The Overlooked Fix for Drug Affordability? Give People More Time to Pay

To make healthcare more affordable in the short term and the long run, time-to-pay must become an essential component of every health plan with any out-of-pocket responsibility.

By Brian Whorley

MedCity Influencers

Lead Quality vs. Lead Volume: What Matters Most When Serving Vulnerable Populations

As scrutiny from CMS and the FCC increases, Medicare marketers must rethink how they source, verify, and engage leads. Taking the focus off lead volume and redirecting it to lead quality will help them demonstrate they run an ethical operation.

By Lisa Leight